TIDMHCM
RNS Number : 2881Z
Hutchmed (China) Limited
12 May 2023
Annual General Meeting held on May 12, 2023 !V Poll Results
Hong Kong, Shanghai, & Florham Park, NJ: Friday, May 12,
2023: HUTCHMED (China) Limited (" HUTCHMED" or the "Company")
(Nasdaq/AIM: HCM; HKEX:13) today announces that all ordinary
resolutions and special resolution put to its Annual General
Meeting ("AGM..) held on May 12, 2023 were duly passed. The poll
results of the resolutions were as follows:
Number of Votes (%)*
Passed
Ordinary Resolutions For Against Withheld(#) by Shareholders
------------ ----------- --------------
To consider and adopt the audited
financial statements, and the
reports of the directors and independent
auditors for the year ended December
1. 31, 2022. 571,825,129 768 17,055,535 Yes
(99.9999%) (0.0001%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Mr TO Chi Keung, Simon
2(A). as a director. 561,123,049 24,976,533 2,781,850 Yes
(95.7385%) (4.2615%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Dr Weiguo SU as a
2(B). director. 587,563,585 1,275,082 42,765 Yes
(99.7835%) (0.2165%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Mr CHENG Chig Fung, 2,037,527
2(C). Johnny as a director. 586,799,765 (0.3460%) 44,140 Yes
(99.6540%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Dr Dan ELDAR as a
2(D). director. 585,955,689 2,882,978 42,765 Yes
(99.5104%) (0.4896%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Ms Edith SHIH as a
2(E). director. 585,511,051 3,327,616 42,765 Yes
(99.4349%) (0.5651%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Mr Lefei SUN as a
2(F). director. 585,955,594 2,883,073 42,765 Yes
(99.5104%) (0.4896%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Mr Paul Rutherford
2(G). CARTER as a director. 588,835,909 1,383 44,140 Yes
(99.9998%) (0.0002%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Mr Graeme Allan JACK
2(H). as a director. 582,880,781 3,218,176 2,782,475 Yes
(99.4509%) (0.5491%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-elect Professor MOK Shu
2(I). Kam, Tony as a director. 575,206,823 13,631,844 42,765 Yes
(97.6850%) (2.3150%)
------------------------------------------ ------------ ----------- -------------- -----------------
To re-appoint PricewaterhouseCoopers
and PricewaterhouseCoopers Zhong
Tian LLP as the auditors of the
Company for Hong Kong financial
reporting and U.S. financial reporting
purposes, respectively, and to
authorize the Directors to fix
3. the auditors' remuneration. 588,053,284 785,368 42,780 Yes
(99.8666%) (0.1334%)
------------------------------------------ ------------ ----------- -------------- -----------------
Special Resolution
To grant a general mandate to
the Directors to issue additional
4. shares of the Company.^ 580,202,630 8,636,037 42,765 Yes
(98.5334%) (1.4666%)
------------------------------------------ ------------ ----------- -------------- -----------------
Ordinary Resolution
To grant a general mandate to
the Directors to repurchase shares
5. of the Company.^ 588,837,389 1,278 42,765 Yes
(99.9998%) (0.0002%)
------------------------------------------ ------------ ----------- -------------- -----------------
* Percentages rounded to 4 decimal places .
(#) A vote withheld is not a vote in law and is not counted in
the calculation of the proportion of the votes for and against a
resolution.
^ The full text of Resolutions 4 and 5 are set out in the Notice
of AGM.
Notes:
(1) Except for Dr Karen Jean FERRANTE who had prior overseas
commitments and was unable to attend the AGM, all directors of the
Company, namely Mr TO Chi Keung, Simon, Dr Weiguo SU, Mr CHENG Chig
Fung, Johnny, Dr Dan ELDAR, Ms Edith SHIH, Mr Lefei SUN, Mr Paul
Rutherford CARTER, Mr Graeme Allan JACK and Professor MOK Shu Kam,
Tony, attended the AGM, either in person or by means of electronic
facilities.
(2) Number of shares entitling the holders to attend and vote on
all the resolutions at the AGM: 866,131,390 shares.
(3) Number of shares entitling the holders to attend and abstain
from voting in favour as set out in Rule 13.40 of the Rules
Governing the Listing of Securities on The Stock Exchange of Hong
Kong Limited (the !--Listing Rules!..) at the AGM: Nil.
(4) Number of shares for holders required under the Listing
Rules to abstain from voting at the AGM: Nil.
(5) The scrutineer for the poll at the AGM was Computershare
Investor Services (Jersey) Limited, the Principal Share Registrar
of the Company.
About HUTCHMED
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative,
commercial-stage, biopharmaceutical company. It is committed to the
discovery and global development and commercialization of targeted
therapies and immunotherapies for the treatment of cancer and
immunological diseases. It has approximately 5,000 personnel across
all its companies, at the center of which is a team of about 1,800
in oncology/immunology. Since inception it has focused on bringing
cancer drug candidates from in-house discovery to patients around
the world, with its first three oncology drugs now approved and
marketed in China. For more information, please visit:
www.hutch--med.com or follow us on LinkedIn .
CONTACTS
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 306 4490
Media Enquiries
Americas - Brad Miles, +1 (917) 570 7340 (Mobile) / bmiles@soleburystrat.com
Solebury Strategic Communications
Europe - Ben Atwell / Alex Shaw, +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055
FTI Consulting (Mobile)
/ HUTCHMED@fticonsulting.com
Asia - Zhou Yi, Brunswick +852 97 83 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley / Daphne Zhang,
Panmure Gordon +44 (20) 7886 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGMSFAFFEEDSELI
(END) Dow Jones Newswires
May 12, 2023 08:15 ET (12:15 GMT)
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
